Novego: Ängste überwinden
DiGA App for Anxiety Disorder · permanently listed
Novego: Ängste überwinden App at a Glance
Novego: Ängste überwinden ist ein psychologisches Online-Unterstützungsprogramm für Menschen, die unter Ängsten leiden. Das Programm basiert auf den Methoden der Kognitiven Verhaltenstherapie, die individuell auf die Angstsymptomatik der Teilnehmerinnen und Teilnehmer abgestimmt werden. Die Inhalte werden verständlich und kreativ aufbereitet und in Form von Texten, Videos, Audios und interaktiven Übungen abwechslungsreich dargestellt. Novego: Ängste überwinden steht den Teilnehmerinnen und Teilnehmern nach der regulären Programmlaufzeit von 6 Wochen weiterhin zur Verfügung, sodass die Inhalte gefestigt und dauerhaft in den Alltag integriert werden können. Zur Gewährleistung der sicheren Anwendung des Produktes und zur Wahrung der Patientensicherheit können die Teilnehmerinnen und Teilnehmer bei Verständnisfragen während der selbständigen Bearbeitung direkt das erfahrene Novego-Team einmal pro Woche per Nachricht kontaktieren. Es erfolgen keine therapeutischen und/oder diagnostischen Maßnahmen durch Novego Mitarbeiterinnen und Mitarbeiter. Für den Fall, dass eine akute Krise auftritt, steht ergänzend zu dem Programm eine 24h-Krisenhotline zur Verfügung. Die Wirksamkeit von Novego bei der Reduktion von Angstsymptomen wurde bereits in einer Studie untersucht und aktuell wird eine weitere Studie durchgeführt.
Novego: Overcoming Fears is a psychological online support program for people who suffer from anxiety. The program is based on the methods of cognitive behavioral therapy, which are individually tailored to the anxiety symptoms of the participants. The content is presented in a comprehensible and creative manner and displayed in a varied format consisting of texts, videos, audios, and interactive exercises. Novego: Overcoming Fears remains available to participants after the regular program duration of 6 weeks, so that the content can be consolidated and permanently integrated into everyday life. To ensure the safe use of the product and to maintain patient safety, participants can directly contact the experienced Novego team once per week via message in case of comprehension questions during independent use. No therapeutic and/or diagnostic measures are carried out by Novego staff. In the event that an acute crisis occurs, a 24-hour crisis hotline is available as a supplement to the program. The effectiveness of Novego in the reduction of anxiety symptoms has already been investigated in a study, and an additional study is currently being conducted.
Automatically translated for informational purposes · Source: BfArM· Updated 10/19/2026
Category
Indicated for
Manufacturer
Listed Since
2023-03-24 - permanently listed
Help and Support for the Novego: Ängste überwinden App
Questions about the app, signing in or the activation code are answered by the manufacturer, IVPNetworks GmbH. We only run this directory and have no access to your app or your account.
Details
Indicated for ICD-10
- F40.0Agoraphobia
- F40.1Social phobias
- F40.2Specific (isolated) phobias
- F41.0Panic disorder [episodic paroxysmal anxiety]
Source: ICD-10 2019 (WHO)
Contraindications
- F00Dementia in Alzheimer disease
- F01Vascular dementia
- F02Dementia in other diseases classified elsewhere
- F03Unspecified dementia
- F04Organic amnesic syndrome, not induced by alcohol and other psychoactive substances
- F05Delirium, not induced by alcohol and other psychoactive substances
- F06Other mental disorders due to brain damage and dysfunction and to physical disease
- F07Personality and behavioural disorders due to brain disease, damage and dysfunction
21 more
- F09Unspecified organic or symptomatic mental disorder
- F10.2Mental and behavioural disorders due to use of alcohol: Dependence syndrome
- F11.2Mental and behavioural disorders due to use of opioids: Dependence syndrome
- F12.2Mental and behavioural disorders due to use of cannabinoids: Dependence syndrome
- F13.2Mental and behavioural disorders due to use of sedatives or hypnotics: Dependence syndrome
- F14.2Mental and behavioural disorders due to use of cocaine: Dependence syndrome
- F15.2Mental and behavioural disorders due to use of other stimulants, including caffeine: Dependence syndrome
- F16.2Mental and behavioural disorders due to use of hallucinogens: Dependence syndrome
- F17.2Mental and behavioural disorders due to use of tobacco: Dependence syndrome
- F18.2Mental and behavioural disorders due to use of volatile solvents: Dependence syndrome
- F19.2Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances: Dependence syndrome
- F20Schizophrenia
- F21Schizotypal disorder
- F22Persistent delusional disorders
- F23Acute and transient psychotic disorders
- F24Induced delusional disorder
- F25Schizoaffective disorders
- F28Other nonorganic psychotic disorders
- F29Unspecified nonorganic psychosis
- F30Manic episode
- F31Bipolar affective disorder
Source: ICD-10 2019 (WHO)
Prescription Period
Einmallizenz
PZN
18726714
How much does the Novego: Ängste überwinden app cost?
Free with statutory health insurance
Health insurance cost: 189.00 EUR for Einmallizenz
Medical Device Risk Class
Risikoklasse I nach MDD
Last changed (BfArM)
10/19/2026
Age Group
Adults (18 years and older)
Additional Devices
none
Languages
German
Where can I find the Novego: Ängste überwinden app?
FAQ
Find all the answers to your questions about the Novego: Ängste überwinden app here.
More DiGAs for Anxiety Disorder
More DiGAs in Mental Health
